In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262).
AUTOR(ES)
Yazawa, K
RESUMO
The in vitro activity of a new fluoroquinolone, tosufloxacin (T-3262), against 111 pathogenic Nocardia strains was studied by an agar dilution method and compared with the activities of other fluoroquinolones. All strains were susceptible to tosufloxacin, and the drug was 2 to 20 times more active than four other quinolones tested. Nocardia farcinica was the Nocardia species most susceptible to tosufloxacin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172836Documentos Relacionados
- In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.
- In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
- In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
- In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against Mycoplasmas
- In vitro susceptibility of Prototheca spp. to gentamicin.
